Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aptorum Group Ltd Cl A (NQ: APM )

3.450 -0.570 (-14.18%)
Official Closing Price Updated: 7:59 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aptorum Group Ltd Cl A

< Previous 1 2 3 Next >
Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases,... 
From Business Wire News Releases
Black & Veatch Sells Data Analytics Solutions Leader Atonix Digital™
Tags APM Black & Veatch Industry, Innovation and Infrastructure
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Aptorum Group Announces Submission of Clinical Trial Application for ALS-4, an Orally Administered Small Molecule Drug for the Treatment of Infections caused by Staphylococcus aureus including Methici
Regulatory News: 
From Business Wire News Releases
Aptorum Group Limited Announces Results of 2020 Annual General Meeting of Shareholders
Regulatory News: 
From Business Wire News Releases
Application Performance Management (APM) Market SWOT Analysis by Key Players Dell Software, Compuware, CA Technologies, BMC Software
Edison, NJ -- (SBWIRE) -- 12/03/2020 -- The Application Performance Management (APM) Market study is a perfect mix of qualitative and quantitative information and to get better understanding on how... 
From SBWire - Latest Press Releases
Application Performance Monitoring (APM) Software Market May Set New Growth Story During 2020 to 2025
Edison, NJ -- (SBWIRE) -- 11/06/2020 -- Application Performance Monitoring (APM) Software Market Size, Status and Forecast 2020-2025 
From SBWire - Latest Press Releases
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020
Regulatory News: 
From Business Wire News Releases
Aptorum Group Announces Closing of $9.0 Million Public Offering
Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today... 
From Business Wire News Releases
Aptorum Group Announces Pricing of $9.0 Million Public Offering
Regulatory News: 
From Business Wire News Releases
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagno
From ACN Newswire
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagno
Regulatory News: 
From Business Wire News Releases
Aptorum Group Ltd. (NASDAQ: APM) (Euronext Paris: APM) Featured in Virtual Coverage of The Wall Street Investor Forum
From InvestorBrandNetwork
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10
From ACN Newswire
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance
From ACN Newswire
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach... 
From Business Wire News Releases
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation therapeutics targeting... 
From Business Wire News Releases
Aptorum Group Announces Video Update Discussing Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics... 
From Business Wire News Releases
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models
From ACN Newswire
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
From ACN Newswire
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020
From ACN Newswire
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and oncology... 
From Business Wire News Releases
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics... 
From Business Wire News Releases
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group” or the “Company”), a biopharmaceutical company focuses on the development of novel therapeutics to address global unmet medical... 
From Business Wire News Releases
Aptorum Group Interview to Air on Bloomberg International on the RedChip Money Report
Regulatory News: 
From Business Wire News Releases
Aptorum Group Limited to Present at The LD 500 Virtual Conference
From ACCESSWIRE
Aptorum Group Limited to Present at The LD 500 Virtual Conference and H.C. Wainwright 22nd Annual Global Life Sciences Conference
Regulatory News: 
From Business Wire News Releases
Aptorum Group Appoints Dr. Herman Weiss as CEO of microbiome-based platform Claves Life Sciences and Dr. Robbie Majzner as scientific advisor to SACT-1 drug for Neuroblastoma and others
Regulatory News: 
From Business Wire News Releases
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM
From ACN Newswire
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM
Regulatory News: 
From Business Wire News Releases
Aptorum Group Prospectus Receives Approval for Listing on the Euronext Paris Stock Exchange
Regulatory News: 
From Business Wire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.